HESKA CORP Income Statement | Understand Stock

Ask AI

Financial Statements

In millions of USD; shares in millions, except per-share amounts

	FY2022 12 months to Dec 31, 2022	FY2021 12 months to Dec 31, 2021	FY2020 12 months to Dec 31, 2020	FY2019 12 months to Dec 31, 2019	FY2018 12 months to Dec 31, 2018
Revenue, net
Core companion animal
Other vaccines and pharmaceuticals
Total revenue, net

Cost of revenue
Gross profit
Operating expenses:
Selling and marketing
Research and development
General and administrative
Total operating expenses
Operating loss
Interest and other expense, net
Net loss before income taxes and equity in losses of unconsolidated affiliates
Income tax (benefit) expense:
Current income tax expense
Deferred income tax benefit
Total income tax (benefit) expense
Net (loss) income before equity in losses of unconsolidated affiliates
Equity in losses of unconsolidated affiliates
Net loss after equity in losses of unconsolidated affiliates
Net loss attributable to redeemable non-controlling interest
Net loss attributable to Heska Corporation
Earnings Per Share
Basic earnings per share attributable to Heska Corporation (in dollars per share)
Diluted earnings per share attributable to Heska Corporation (in dollars per share)
Weighted average outstanding shares used to compute basic loss per share attributable to Heska Corporation
Weighted average outstanding shares used to compute diluted loss per share attributable to Heska Corporation

Comments